U.S. federal trademark · Serial No. 78963551
Blood, blood derivatives, pharmaceuticals derived from recombinant DNA Technology all for medical use in the prevention and treatment of blood disorders; intravenous immunoglobulins for use in treatment of immunodeficiency disorders and in immune replacement therapy
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.